Plectin in cancer: from biomarker to therapeutic target

SM Perez, LT Brinton, KA Kelly - Cells, 2021 - mdpi.com
The cytolinker and scaffolding protein, plectin, has emerged as a potent driver of malignant
hallmarks in many human cancers due to its involvement in various cellular activities …

Replication-dependent histone isoforms: a new source of complexity in chromatin structure and function

R Singh, E Bassett, A Chakravarti… - Nucleic acids …, 2018 - academic.oup.com
Replication-dependent histones are expressed in a cell cycle regulated manner and supply
the histones necessary to support DNA replication. In mammals, the replication-dependent …

iTRAQ underestimation in simple and complex mixtures:“the good, the bad and the ugly”

SY Ow, M Salim, J Noirel, C Evans… - Journal of proteome …, 2009 - ACS Publications
The increasing popularity of iTRAQ for quantitative proteomics applications makes it
necessary to evaluate its relevance, accuracy, and precision for biological interpretation …

iTRAQ identification of candidate serum biomarkers associated with metastatic progression of human prostate cancer

I Rehman, CA Evans, A Glen, SS Cross, CL Eaton… - PloS one, 2012 - journals.plos.org
A major challenge in the management of patients with prostate cancer is identifying those
individuals at risk of developing metastatic disease, as in most cases the disease will remain …

Comparative proteomics analysis suggests that placental mitochondria are involved in the development of pre-eclampsia

Z Shi, W Long, C Zhao, X Guo, R Shen, H Ding - PloS one, 2013 - journals.plos.org
Introduction Pre-eclampsia (PE), a severe pregnancy-specific disease characterized by the
new onset of hypertension, proteinuria, edema, and a series of other systematic disorders, is …

[HTML][HTML] Proteomic profiling of skeletal and cardiac muscle in cancer cachexia: alterations in sarcomeric and mitochondrial protein expression

AMY Shum, A Poljak, NL Bentley, N Turner, TC Tan… - Oncotarget, 2018 - ncbi.nlm.nih.gov
Background Cancer cachexia is observed in more than 50% of advanced cancer patients,
and impairs quality of life and prognosis. A variety of pathways are likely to be dysregulated …

Mass spectrometry‐based characterization of histones in clinical samples: applications, progress, and challenges

R Noberini, G Robusti, T Bonaldi - The FEBS Journal, 2022 - Wiley Online Library
In the last 15 years, increasing evidence linking epigenetics to various aspects of cancer
biology has prompted the investigation of histone post‐translational modifications (PTMs) …

Transcriptome and proteome profiling of different colored rice reveals physiological dynamics involved in the flavonoid pathway

X Chen, Y Tao, A Ali, Z Zhuang, D Guo, Q Guo… - International journal of …, 2019 - mdpi.com
Black and red rice are rich in both anthocyanin and proanthocyanin content, which belong to
a large class of flavonoids derived from a group of phenolic secondary metabolites …

A novel RNA aptamer identifies plasma membrane ATP synthase beta subunit as an early marker and therapeutic target in aggressive cancer

S Speransky, P Serafini, J Caroli, S Bicciato… - Breast cancer research …, 2019 - Springer
Purpose Primary breast and prostate cancers can be cured, but metastatic disease cannot.
Identifying cell factors that predict metastatic potential could guide both prognosis and …

Depletion of the actin bundling protein SM22/transgelin increases actin dynamics and enhances the tumourigenic phenotypes of cells

O Thompson, JS Moghraby, KR Ayscough, SJ Winder - BMC cell biology, 2012 - Springer
Background SM22 has long been studied as an actin-associated protein. Interestingly,
levels of SM22 are often reduced in tumour cell lines, while they are increased during …